A850S (p.Ala850Ser) variant of CACNA2D2 (Q9NY47)
A850S (p.Ala850Ser) in CACNA2D2 (Q9NY47) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
A850S (p.Ala850Ser) variant details
- p.Ala850Ser
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.29
- MetaSVM -0.65
- SIFT 0.00
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available